# Patient-Focused Drug Development: Collecting Comprehensive and Representative Input - FDA Guidance Document Source: https://www.globalkeysolutions.net/guidances/guidance-document/patient-focused-drug-development-collecting-comprehensive-and-representative-input/abbf838a-9294-4c1b-a0d1-55c963831af5 > FDA guidance document: Patient-Focused Drug Development: Collecting Comprehensive and Representative Input. Issue date: June 13, 2018. Get complete insights and analysis. --- ## Details - Title: Patient-Focused Drug Development: Collecting Comprehensive and Representative Input - Communication Type: Guidance Document - Product Type: drugs - Office Name: Center for Drug Evaluation and Research - Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c - Issue Date: 2018-06-13 - Comment Close Date: 2018-09-12 - Last Changed: 2021-01-26 - Docket Number: FDA-2018-D-1893 ## Related Documents - [Patient-Focused Drug Development: Methods to Identify What Is Important to Patients: Guidance for Industry, Food and Drug Administration Staff, and Other Stakeholders](https://www.globalkeysolutions.net/guidances/guidance-document/patient-focused-drug-development-methods-to-identify-what-is-important-to-patients-guidance-for-industry-food-and-drug-administration-staff-and-other-stakeholders/06de176c-365a-43ad-84f7-7aa3926833b5) - [General Clinical Pharmacology Considerations for Neonatal Studies for Drugs and Biological Products Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/general-clinical-pharmacology-considerations-for-neonatal-studies-for-drugs-and-biological-products-guidance-for-industry/0c57731e-55bc-4962-a619-54444aa22335) - [Qualification Process for Drug Development Tools Guidance for Industry and FDA Staff](https://www.globalkeysolutions.net/guidances/guidance-document/qualification-process-for-drug-development-tools-guidance-for-industry-and-fda-staff/f5a3f8af-54f6-44ba-9eea-d3cc587444f7)